ProShare Advisors
PNT

ProShare Advisors’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

ProShare Advisors’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,754
Closed -$78.4K – 1980
2023
Q3 		$78.4K Sell
11,754
-14
-0.1% -$116 ﹤0.01% 1670
2023
Q2 		$107K Buy
11,768
+1,550
+15% +$13.7K ﹤0.01% 1688
2023
Q1 		$74.3K Sell
10,218
-781
-7% -$5.79K ﹤0.01% 1632
2022
Q4 		$80.2K Buy
+10,999
New +$81.6K ﹤0.01% 1690

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

ProShare Advisors's PNT Position: Q4 2023 in Review

ProShare Advisors sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 11,754 shares — an estimated $78.4K sold.

ProShare Advisors first reported a position in PNT in Q4 2022 and held it in 4 quarters. The position peaked at $107K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • ProShare Advisors reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • ProShare Advisors sold 11,754 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $78.4K.
  • ProShare Advisors first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • ProShare Advisors's POINT Biopharma Global Inc. Common Stock position peaked at $107K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on ProShare Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.